MedTrace Logo

Using Digestive Microbial Information to Enhance the Early Detection of Pancreatic Cancer

NCT05689138 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-01-18

No results posted yet for this study

Summary

Pancreatic cancer (PCA) is a leading death-related cancer. There is an urgent need for accurate, noninvasive diagnostic options in the early detection of pancreatic cancer (PCA), since delayed diagnosis increases the risk of metastasis and recurrence. In this study, by analyzing gut and fecal microbial data among the pancreatic versus healthy populations, we aim to establish an early detection tool to improve PCA detection, and to explore potential diagnostic biomarkers.

Conditions

Interventions

OTHER

Oral and Fecal Sample Collection

No interventions

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    lead OTHER

Principal Investigators

  • Menghua Dai, MD · Peking Union Medical College Hospital

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2023-12-30
Completion
2023-12-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05689138 on ClinicalTrials.gov